Schedule 13D ownership disclosure

CUE BIOPHARMA INC

Security class unavailable · CUSIP: 22978P106

Event date: 2020-04-21

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
4.8700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-20-006833
Form type
SC 13D/A
Filer
Cue Biopharma, Inc.
CIK
CIK 1645460
Filed
Apr 21, 2020
Reporting period
Apr 21, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub